UBS Group’s Pyxis Oncology PYXS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $436K | Sell |
396,096
-748
| -0.2% | -$823 | ﹤0.01% | 4949 |
|
|
2025
Q1 | $389K | Sell |
396,844
-49,855
| -11% | -$48.9K | ﹤0.01% | 4851 |
|
|
2024
Q4 | $697K | Buy |
446,699
+418,597
| +1,490% | +$653K | ﹤0.01% | 4489 |
|
|
2024
Q3 | $103K | Buy |
28,102
+10,424
| +59% | +$38.3K | ﹤0.01% | 5145 |
|
|
2024
Q2 | $58.5K | Sell |
17,678
-10,572
| -37% | -$35K | ﹤0.01% | 5427 |
|
|
2024
Q1 | $120K | Buy |
28,250
+25,295
| +856% | +$108K | ﹤0.01% | 4983 |
|
|
2023
Q4 | $5.32K | Hold |
2,955
| – | – | ﹤0.01% | 6586 |
|
|
2023
Q3 | $5.88K | Sell |
2,955
-4,695
| -61% | -$9.34K | ﹤0.01% | 6195 |
|
|
2023
Q2 | $19.6K | Buy |
7,650
+4,695
| +159% | +$12K | ﹤0.01% | 5807 |
|
|
2023
Q1 | $11.9K | Buy |
+2,955
| New | +$11.9K | ﹤0.01% | 6380 |
|
|
2022
Q4 | – | Sell |
-155
| Closed | – | – | 9746 |
|
|
2022
Q3 | $0 | Sell |
155
-212
| -58% | – | ﹤0.01% | 9592 |
|
|
2022
Q2 | $1K | Sell |
367
-1,065
| -74% | -$2.9K | ﹤0.01% | 8894 |
|
|
2022
Q1 | $6K | Sell |
1,432
-3,386
| -70% | -$14.2K | ﹤0.01% | 7927 |
|
|
2021
Q4 | $53K | Buy |
+4,818
| New | +$53K | ﹤0.01% | 5749 |
|